ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.91
      1.09%
      US Tech 100
      18,104.00
      1.50%
      Dow Jones
      39,862.58
      0.77%
      Brent Oil
      82.675
      0.15%
      Bitcoin
      65,945.99
      7.15%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Forward Pharma AS (FWP)

      7. Forward Pharma AS (FWP) News

      FWP

      Forward Pharma AS (FWP)

      Forward Pharma AS
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FWP
      DateTimeSourceHeadlineSymbolCompany
      2:30PMiHub NewswireFeaturedIntegrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share
      02/14/20234:04PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FWPForward Pharma AS
      01/24/20236:08AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FWPForward Pharma AS
      01/13/20234:43PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      01/06/20239:16AMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:FWPForward Pharma AS
      12/19/20226:04AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      12/19/20226:00AMGlobeNewswire Inc.Forward Pharma Announces Expected Delisting of its American Depositary Shares from the Nasdaq Capital MarketNASDAQ:FWPForward Pharma AS
      12/06/20222:24PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      12/06/20222:00PMGlobeNewswire Inc.Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for ReviewNASDAQ:FWPForward Pharma AS
      11/21/20225:07PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      11/09/20224:47PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      07/07/20224:35PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      05/20/20224:36PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      05/05/20225:40PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      05/02/20224:56PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      04/08/20225:25PMGlobeNewswire Inc.Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021NASDAQ:FWPForward Pharma AS
      02/14/202212:59PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FWPForward Pharma AS
      12/27/20216:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FWPForward Pharma AS
      12/13/20215:04PMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:FWPForward Pharma AS
      12/13/20215:02PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FWPForward Pharma AS
      10/12/20215:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      09/07/20217:01AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      09/06/202110:21AMGlobeNewswire Inc.Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal HearingNASDAQ:FWPForward Pharma AS
      06/08/20215:00PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      05/28/20218:00AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      05/27/20215:02PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      05/04/20216:08AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      04/15/20215:07PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      04/15/20215:01PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:FWPForward Pharma AS
      04/14/20214:40PMGlobeNewswire Inc.Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020NASDAQ:FWPForward Pharma AS
       Showing the most relevant articles for your search:NASDAQ:FWP

      Your Recent History

      HITB
      RETH
      Revain
      COIN
      STPTEUR
      Standard Tokenization Protocol
      Delayed Upgrade Clock